CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity
H. Mark Kenney(University of Rochester Medical Center), Lisa A. Beck(University of Rochester Medicine), Peck Y. Ong(Children's Hospital of Los Angeles), Eric L. Simpson(Oregon Health & Science University), Justin Ko(Stanford University), Donald Y.M. Leung(Boston Children's Hospital), Steven R. Gill(University of Rochester Medical Center), Evgeny Berdyshev(National Jewish Health), Mark Boguniewicz(University of Colorado Denver), Anna De Benedetto(University of Rochester Medicine), Stephanie Lussier(Buck Institute for Research on Aging), Zelma C. Chiesa Fuxench(University of Pennsylvania), Takeshi Yoshida(University of Rochester Medicine), Patrick M. Schlievert(University of Iowa), Tissa Hata(University of California San Diego), Agustin Calatroni(Johns Hopkins University), Gloria L. David(Rho (United States)), Wendy F. Davidson(National Institutes of Health)
Cited by 9
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k